RNAZ
NASDAQ · Biotechnology
Transcode Therapeutics Inc
$1.32
-0.07 (-5.06%)
Open$1.43
Previous Close$1.39
Day High$1.45
Day Low$1.30
52W High$12.60
52W Low$1.33
Volume—
Avg Volume17.0K
Market Cap22.35M
P/E Ratio—
EPS$-47.00
SectorBiotechnology
Analyst Ratings
Strong Buy
7 analysts
Price Target
+1,401.5% upside
Current
$1.32
$1.32
Target
$19.82
$19.82
$14.35
$19.82 avg
$27.60
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 2.00M | 1.95M | 1.64M |
| Net Income | -582,985 | -504,236 | -420,334 |
| Profit Margin | -29.1% | -25.9% | -25.6% |
| EBITDA | -690,102 | -649,673 | -530,744 |
| Free Cash Flow | -724,048 | -502,155 | -609,665 |
| Rev Growth | -0.1% | -1.2% | +14.7% |
| Debt/Equity | 1.05 | 0.94 | 0.99 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $295.03 | +0.20% | 50.3 | 520.47B |
| AMGN | Amgen Inc | $465.67 | -0.30% | 26.9 | 252.64B |
| GILD | Gilead Sciences Inc | $168.08 | +0.08% | — | 208.95B |
| VRTX | Vertex Pharmaceuticals Inc | $538.60 | -0.74% | 33.9 | 134.82B |
| REGN | Regeneron Pharmaceuticals | $955.47 | +0.45% | 20.4 | 98.38B |
| ALNY | Alnylam Pharmaceuticals Inc | $165.04 | +5.36% | 7.7 | 20.98B |